Fig. 4From: The impact of relaxing restrictions on take-home doses during the COVID-19 pandemic on program effectiveness and client experiences in opioid agonist treatment: a mixed methods systematic reviewSubgroup analysis of retention and overdose by treatment typeBack to article page